- [1] . A novel drug combination of Tofacitinib and Iguratimod alleviates rheumatoid arthritis and secondary osteoporosis. International Immunopharmacology 201, 124, 2023.
- [2] . Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF T, 119, e2117054119, 2022.
- [3] 孙姣. Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis. Scientific reports, 11, 2021.
- [4] 李洁. Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. BONE RESEARCH, 7, 2019.
| |